iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by Advisory Services Network LLC

Advisory Services Network LLC lowered its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 11.0% in the fourth quarter, Holdings Channel reports. The institutional investor owned 4,463 shares of the financial services provider’s stock after selling 553 shares during the period. Advisory Services Network LLC’s holdings in iShares Biotechnology ETF were worth $590,000 as of its most recent filing with the SEC.

Other hedge funds have also modified their holdings of the company. Raymond James Financial Inc. purchased a new position in shares of iShares Biotechnology ETF during the 4th quarter worth about $55,010,000. Aprio Wealth Management LLC acquired a new position in shares of iShares Biotechnology ETF in the 4th quarter valued at $18,476,000. Generali Investments CEE investicni spolecnost a.s. purchased a new stake in shares of iShares Biotechnology ETF during the 4th quarter valued at $11,370,000. Independent Advisor Alliance acquired a new stake in shares of iShares Biotechnology ETF during the 4th quarter worth $6,769,000. Finally, Wellington Shields Capital Management LLC raised its position in shares of iShares Biotechnology ETF by 1,753.4% in the 4th quarter. Wellington Shields Capital Management LLC now owns 39,663 shares of the financial services provider’s stock worth $5,244,000 after buying an additional 37,523 shares during the period. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Price Performance

Shares of NASDAQ:IBB opened at $119.85 on Wednesday. The business has a 50-day moving average of $130.88 and a two-hundred day moving average of $136.32. The firm has a market capitalization of $5.36 billion, a PE ratio of 24.21 and a beta of 0.84. iShares Biotechnology ETF has a 12 month low of $107.43 and a 12 month high of $150.57.

iShares Biotechnology ETF Increases Dividend

The firm also recently announced a dividend, which was paid on Friday, March 21st. Investors of record on Tuesday, March 18th were given a dividend of $0.1212 per share. The ex-dividend date was Tuesday, March 18th. This is an increase from iShares Biotechnology ETF’s previous dividend of $0.06.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.